Form D · Pharmaceuticals
Intekrin Therapeutics Inc
Los Altos, CA · CIK 0001360245
Offering snapshot reported Jun 14, 2010 · SEC filing
- Reported sold
- $2.29M Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 28, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 14, 2010 | Initial | $2,292,809 | No comparison | 2 | SEC filing |
| Apr 2, 2009 | Initial | $21,391,923 | No comparison | Not reported | SEC filing |
| Jul 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 22, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 18, 2006 | Paper | Not reported | No comparison | Not reported | |
| Apr 18, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-143415
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Jun 14, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David M. Brand | Director |
| Alex M. De Paoli, M.D. | Executive |
| Martin I. Freed, M.D., Facp | Director |
| James I. Healy, M.D., Ph.D. | Director |
| Linda Slanec Higgins | Executive |
| Linda Slanec Higgins, Ph.D. | Director, Executive |
| Dennis M. Lanfear | Director, Executive |
| Kathleen M. Lee, Ph.D. | Executive |
| David G. Lowe, Ph.D. | Director |
| Michael A. Nazak | Executive |
| Geoffrey M. Parker | Executive |
| Carmen R. Rodriguez, M.Sc. | Executive |
| Carmen R. Rodriguez, M.S.C | Executive |
| Lowell E. Sears | Director |
| Harold E. Selick, Ph.D. | Director |
| Roman J. Skowronski, M.D., Ph.D. | Executive |
| Samuel P. Wertheimer, Ph.D. | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4300 El Camino Real Suite 201
Los Altos, CA, 94022
Los Altos, CA, 94022